Nobody would be ghoulish enough to delay approval
Post# of 144904
![](/assets/46931549/no_avatar_available_thumb.jpg)
I'm in the camp that the FDA wants the data to justify approval.
Where I fault the FDA is not realizing our MOA made LL a frontrunner back in the spring, at which point they should have helped with money and resources to expedite the trial and get the S/C results in the summer.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)